La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Hanall Biopharma Dividende
Dividende contrôle des critères 0/6
Hanall Biopharma does not have a record of paying a dividend.
Informations clés
n/a
Rendement du dividende
n/a
Ratio de distribution
| Rendement moyen de l'industrie | 1.1% |
| Prochaine date de paiement du dividende | n/a |
| Date ex-dividende | n/a |
| Dividende par action | n/a |
| Résultat par action | ₩87.56 |
| Prévisions de rendement du dividende à 3 ans | n/a |
Mises à jour récentes des dividendes
Pas de mise à jour
Recent updates
Calculating The Intrinsic Value Of Hanall Biopharma Co., Ltd. (KRX:009420)
Jun 26
Getting In Cheap On Hanall Biopharma Co., Ltd. (KRX:009420) Is Unlikely
May 22There May Be Underlying Issues With The Quality Of Hanall Biopharma's (KRX:009420) Earnings
Mar 13Introducing Hanall BiopharmaLtd (KRX:009420), The Stock That Zoomed 103% In The Last Five Years
Feb 12What Kind Of Investors Own Most Of Hanall Biopharma Co.,Ltd (KRX:009420)?
Jan 25
Hanall Biopharma Co.,Ltd's (KRX:009420) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Jan 04Hanall BiopharmaLtd (KRX:009420) Is Growing Earnings But Are They A Good Guide?
Dec 14Here's Why We Think Hanall BiopharmaLtd (KRX:009420) Is Well Worth Watching
Nov 21Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: Insufficient data to determine if A009420's dividends per share have been stable in the past.
Dividende croissant: Insufficient data to determine if A009420's dividend payments have been increasing.
Rendement des dividendes par rapport au marché
| Hanall Biopharma Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (A009420) | n/a |
| 25% du marché (KR) | 1.1% |
| 25% du marché (KR) | 3.8% |
| Moyenne du secteur (Pharmaceuticals) | 1.1% |
| Prévisions des analystes dans 3 ans (A009420) | n/a |
Dividende notable: Unable to evaluate A009420's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Dividende élevé: Unable to evaluate A009420's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Bénéfice distribué aux actionnaires
Couverture des revenus: Insufficient data to calculate A009420's payout ratio to determine if its dividend payments are covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as A009420 has not reported any payouts.